|
|
|
Invited
Speakers
|
|
Dr. Ann-Lii Cheng, College of Medicine National Taiwan University,
Taiwan
|
Prof. C. S. Chen, PhD., College of Pharmacy, Ohio State University,
USA
|
Dr. Cheng-Der Tony Yu,
President & Chief Scientific Officer, Canyon Pharmaceuticals, Inc.,
Hunt Valley, Maryland, USA. |
Dr. Chih Yung Ho, Research Fellow, Drug Discovery, R. W. Johnson Pharmaceutical
Research
¡@ Institute, NJ, USA. |
Dr.
Alex Matter, M.D., Director, Novartis Institute for Tropical
Diseases |
Pro.
Edwin S.C. Wu, Ph.D., President and CSO, Jenken Biosciences, Inc. |
Dr. Frank Martin, Chief
Scientific Officer, iMEDD, Inc, USA. |
Dr. George K.K Lau, Assistant Dean of Faculty of Medicine. The University
of Hong Kon, China. |
Dr.
John Kavanagh, MD, Houston, USA |
Dr. Kwen-Jen (Ken) Chang, President-Asia Pacific Operations & chief
science Officer Enhance
¡@ Biotech Inc., USA. |
Dr. Kuei-Ying Lin, Group Leader, Drug Discovery. Gilead Sciences,
Inc. USA. |
Dr. Keelung Hong, Chairman & CEO, Taiwan Liposome Company, Taipei,
Taiwan. |
Dr. Laurence I. Wu, Vice President, Drug Discovery. PharmaEssentia
Corp. |
Dr. Marie-Therese Martin, Associate Director, Late Development HPV Vaccine, Belgium
Corp. |
Dr. Tung-Ping Su, Yang Ming Medical University, Taiwan. |
Dr. Wendy B. Young, Senior Director, Medicinal Chemistry, Celera,
San Francisco, USA. |
Dr. Yao-Chang Xu, Head of Discovery Chemistry Research, Lilly Research
Laboratories, Lilly
¡@ Corporate Center, USA. |
Dr. Yale Mitchel, Executive Director, Clinical Research Merck & Co.,
Inc. USA. |
Dr. Yibin Xiang, Senior Director, Medicinal Chemistry Genzyme Corporation,
USA. |
Prof. Zeiwei Huang, PhD., Professor and Director of Medicinal Chemistry,The
Burnham Institute,
¡@ San Diego, USA |
|